3172 results for «502»
3172 results
Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES
19 May 2022 – From EuroPCR 2022
Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.
State-of-the-art imaging for structural heart disease interventions
19 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to focus on imaging and help understand what imaging has changed in recent years: learn how to perform pre-procedural planning and how advanced imaging can make procedures easier and safer.
Robotic PCI: evolution or R-Evolution
19 May 2022 – From EuroPCR 2022
Consult this session including a recorded case, and learn more about robotic PCI - its benefits and recent clinical results. Discover what might be the future of robotic PCI.
The role of coronary interventionalist in TAVI - From referral to timing of PCI
19 May 2022 – From EuroPCR 2022
Consult this session to learn how to contribute to streamlined pre- and post-TAVI patient pathways, to discover updates on the optimised TAVI procedure and appreciate the variances in different valve designs and the long-term patient outcomes, as well as to discuss the right time of PCI in TAVI patients...
PCI in calcified left main stenosis: tools and techniques to warrant a safe and predictable outcome
19 May 2022 – From EuroPCR 2022
Consult this session to find out about the importance of intravascular imaging to guide left main PCI, to learn how to safely and effectively adopt advanced plaque modification tools and techniques, as well as to appraise the proper stent selection and tailored stenting technique to the target left main...
Nothing to fear - a guide to combine DCB and DES in hybrid PCI
19 May 2022 – From EuroPCR 2022
DCB in in-stent restenosis, DCB and DES, DCB in ACS, and a guide to use DCB in de novo lesions and bifurcations: this is the programme of this EuroPCR 2022 session devoted, not surprisingly, to drug-coated balloons.
TriClip therapy: here now, here to stay
19 May 2022 – From EuroPCR 2022
Discover how tricuspid clip dedicated therapy allows treating a broad range of anatomies through real-life cases. Also, learn about its real-world outcomes and the performance in different tricuspid regurgitation patient profiles.
Imaging in LAA occlusion: from planning to final assessment
19 May 2022 – From EuroPCR 2022
Consult this session to learn about imaging supporting LAA occlusion procedure, how to combine different imaging techniques to guide this intervention and their value for procedure planning.
The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI
19 May 2022 – From EuroPCR 2022
Consult this session to learn more about the characteristics of atrial fibrillation patients undergoing TAVI, the priority of stroke prevention in atrial fibrillation patients post-TAVI, as well as the current understanding in Japanese and Asian patients.
A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation
19 May 2022 – From EuroPCR 2022
In this session from EuroPCR 2022, the speakers introduce different options available for treating tricuspid regurgitation. They discuss the anatomical considerations that define suitable candidates and review different transcatheter options and their key differentiators.
What's next in DES technology? Innovative DES platforms combining DES with DCB
19 May 2022 – From EUROPCR 2022
Via a series of case presentations, learn more about the dual drug delivery from DES and DCB platform to treat diabetes mellitus patients. Understand its efficiency in a complex setting and see how a no-polymer DES and DCB platform can fill the gaps of the unmet...
ISCHEMIA-CKD EXTEND: revascularization does not improve outcomes at 5 years in patients with advanced chronic kidney disease
29 Aug 2022
Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results - clinical outcomes at 5 years of follow-up, which were presented during the ESC 2022 congress in Barcelona.
Author
